3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Liver Neoplasms
1
Glioma
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Advanced Breast Cancer
1
Interventions
Magnetic Resonance Spectroscopy
5
trametinib
3
Specimen Handling
3
dabrafenib
2
cabozantinib
2
X-Rays
2
Iodine-131
2
Interviews as Topic
2
tremelimumab
1
spartalizumab
1
pembrolizumab
1
omipalisib
1
lenvatinib
1
gallium Ga 68 dotatate
1
durvalumab
1
cobimetinib
1
Vemurafenib
1
Thyrotropin Alfa
1
Sodium Iodide
1
Phantoms, Imaging
1
Nivolumab
1
Ipilimumab
1
Iodine-124
1
High-Energy Shock Waves
1
Glycoprotein Hormones, alpha Subunit
1
Counseling
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma, Follicular
×
Ritonavir
×
1 year
×
Clear all
No trials found.